> top > docs > PMC:1448208 > spans > 124-519 > annotations

PMC:1448208 / 124-519 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T853 0-5 NN denotes Maple
T854 6-11 NN denotes Syrup
T855 18-25 NN denotes Disease
T856 12-17 NN denotes Urine
T857 33-35 VBZ denotes is
T858 26-27 -LRB- denotes (
T859 27-31 NN denotes MSUD
T860 31-32 -RRB- denotes )
T861 36-38 DT denotes an
T862 46-51 NN denotes error
T863 39-45 JJ denotes inborn
T864 52-54 IN denotes of
T865 55-65 NN denotes metabolism
T866 66-72 VBN denotes caused
T867 73-75 IN denotes by
T868 76-77 DT denotes a
T869 78-88 NN denotes deficiency
T870 89-91 IN denotes of
T871 92-100 VBN denotes branched
T872 101-106 NN denotes chain
T873 100-101 HYPH denotes -
T874 117-130 NN denotes dehydrogenase
T875 107-111 NN denotes keto
T876 112-116 NN denotes acid
T877 130-131 . denotes .
T878 131-214 sentence denotes MSUD has several clinical phenotypes depending on the degree of enzyme deficiency.
T879 132-136 NN denotes MSUD
T880 137-140 VBZ denotes has
T881 141-148 JJ denotes several
T882 158-168 NNS denotes phenotypes
T883 149-157 JJ denotes clinical
T884 169-178 VBG denotes depending
T885 179-181 IN denotes on
T886 182-185 DT denotes the
T887 186-192 NN denotes degree
T888 193-195 IN denotes of
T889 196-202 NN denotes enzyme
T890 203-213 NN denotes deficiency
T891 213-214 . denotes .
T892 214-305 sentence denotes Current treatments are not satisfactory and require new approaches to combat this disease.
T893 215-222 JJ denotes Current
T894 223-233 NNS denotes treatments
T895 234-237 VBP denotes are
T896 238-241 RB denotes not
T897 242-254 JJ denotes satisfactory
T898 255-258 CC denotes and
T899 259-266 VBP denotes require
T900 267-270 JJ denotes new
T901 271-281 NNS denotes approaches
T902 282-284 TO denotes to
T903 285-291 VB denotes combat
T904 292-296 DT denotes this
T905 297-304 NN denotes disease
T906 304-305 . denotes .
T907 305-395 sentence denotes A major hurdle in developing new treatments has been the lack of a suitable animal model.
T908 306-307 DT denotes A
T909 314-320 NN denotes hurdle
T910 308-313 JJ denotes major
T911 354-358 VBN denotes been
T912 321-323 IN denotes in
T913 324-334 VBG denotes developing
T914 335-338 JJ denotes new
T915 339-349 NNS denotes treatments
T916 350-353 VBZ denotes has
T917 359-362 DT denotes the
T918 363-367 NN denotes lack
T919 368-370 IN denotes of
T920 371-372 DT denotes a
T921 389-394 NN denotes model
T922 373-381 JJ denotes suitable
T923 382-388 NN denotes animal
T924 394-395 . denotes .
R13 T853 T854 compound Maple,Syrup
R14 T854 T855 compound Syrup,Disease
R15 T855 T857 nsubj Disease,is
R17 T858 T855 punct (,Disease
R18 T859 T855 appos MSUD,Disease
R19 T860 T857 punct ),is
R20 T861 T862 det an,error
R21 T862 T857 attr error,is
R23 T864 T862 prep of,error
R24 T865 T864 pobj metabolism,of
R25 T866 T862 acl caused,error
R26 T867 T866 agent by,caused
R27 T868 T869 det a,deficiency
R28 T869 T867 pobj deficiency,by
R29 T870 T869 prep of,deficiency
R30 T871 T872 amod branched,chain
R31 T872 T874 compound chain,dehydrogenase
R33 T874 T870 pobj dehydrogenase,of
R36 T877 T857 punct .,is
R37 T879 T880 nsubj MSUD,has
R38 T881 T882 amod several,phenotypes
R39 T882 T880 dobj phenotypes,has
R41 T884 T880 prep depending,has
R42 T885 T884 prep on,depending
R43 T886 T887 det the,degree
R44 T887 T885 pobj degree,on
R45 T888 T887 prep of,degree
R46 T889 T890 compound enzyme,deficiency
R47 T890 T888 pobj deficiency,of
R48 T891 T880 punct .,has
R49 T893 T894 amod Current,treatments
R50 T894 T895 nsubj treatments,are
R51 T896 T895 neg not,are
R52 T897 T895 acomp satisfactory,are
R53 T898 T895 cc and,are
R54 T899 T895 conj require,are
R55 T900 T901 amod new,approaches
R56 T901 T899 dobj approaches,require
R57 T902 T903 aux to,combat
R58 T903 T899 advcl combat,require
R59 T904 T905 det this,disease
R60 T905 T903 dobj disease,combat
R61 T906 T895 punct .,are
R62 T908 T909 det A,hurdle
R63 T909 T911 nsubj hurdle,been
R65 T912 T909 prep in,hurdle
R66 T913 T912 pcomp developing,in
R67 T914 T915 amod new,treatments
R68 T915 T913 dobj treatments,developing
R69 T916 T911 aux has,been
R70 T917 T918 det the,lack
R71 T918 T911 attr lack,been
R72 T919 T918 prep of,lack
R73 T920 T921 det a,model
R74 T921 T919 pobj model,of
R77 T924 T911 punct .,been
R16 T856 T855 compound Urine,Disease
R22 T863 T862 amod inborn,error
R32 T873 T872 punct -,chain
R34 T875 T876 compound keto,acid
R35 T876 T874 compound acid,dehydrogenase
R40 T883 T882 amod clinical,phenotypes
R64 T910 T909 amod major,hurdle
R75 T922 T921 amod suitable,model
R76 T923 T921 compound animal,model

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T776 0-5 NCBITaxon:4022 denotes Maple
T777 12-17 UBERON:0001088 denotes Urine
T778 55-65 GO:0008152 denotes metabolism
T779 107-116 CHEBI:25754 denotes keto acid
T780 196-202 CHEBI_GO_SO_EXT:enzyme denotes enzyme
T781 382-388 NCBITaxon:33208 denotes animal

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T729 0-5 NCBITaxon:4022 denotes Maple
T730 12-17 UBERON:0001088 denotes Urine
T731 55-65 GO:0008152 denotes metabolism
T732 107-116 CHEBI:25754 denotes keto acid
T733 382-388 NCBITaxon:33208 denotes animal